Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: MTAP-deleted Solid Tumors, Advanced Solid Tumors.
Sponsors: Bayer.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has 2 clinical trials on record, with 2 currently active. Their work covers MTAP-deleted Solid Tumors, Advanced Solid Tumors.
Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.